BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 10741393)

  • 1. 2B4 functions as a co-receptor in human NK cell activation.
    Sivori S; Parolini S; Falco M; Marcenaro E; Biassoni R; Bottino C; Moretta L; Moretta A
    Eur J Immunol; 2000 Mar; 30(3):787-93. PubMed ID: 10741393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.
    Moretta A; Bottino C; Vitale M; Pende D; Cantoni C; Mingari MC; Biassoni R; Moretta L
    Annu Rev Immunol; 2001; 19():197-223. PubMed ID: 11244035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells.
    Parolini S; Bottino C; Falco M; Augugliaro R; Giliani S; Franceschini R; Ochs HD; Wolf H; Bonnefoy JY; Biassoni R; Moretta L; Notarangelo LD; Moretta A
    J Exp Med; 2000 Aug; 192(3):337-46. PubMed ID: 10934222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD59 is physically and functionally associated with natural cytotoxicity receptors and activates human NK cell-mediated cytotoxicity.
    Marcenaro E; Augugliaro R; Falco M; Castriconi R; Parolini S; Sivori S; Romeo E; Millo R; Moretta L; Bottino C; Moretta A
    Eur J Immunol; 2003 Dec; 33(12):3367-76. PubMed ID: 14635045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.
    Brando C; Mukhopadhyay S; Kovacs E; Medina R; Patel P; Catina TL; Campbell KS; Santoli D
    J Leukoc Biol; 2005 Aug; 78(2):359-71. PubMed ID: 15937142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of 2B4 (CD244)-mediated NK cell activation by ligand-induced receptor modulation.
    Sandusky MM; Messmer B; Watzl C
    Eur J Immunol; 2006 Dec; 36(12):3268-76. PubMed ID: 17111350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion.
    Bryceson YT; March ME; Ljunggren HG; Long EO
    Blood; 2006 Jan; 107(1):159-66. PubMed ID: 16150947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome.
    Tangye SG; Phillips JH; Lanier LL; Nichols KE
    J Immunol; 2000 Sep; 165(6):2932-6. PubMed ID: 10975798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The murine NK receptor 2B4 (CD244) exhibits inhibitory function independent of signaling lymphocytic activation molecule-associated protein expression.
    Mooney JM; Klem J; Wülfing C; Mijares LA; Schwartzberg PL; Bennett M; Schatzle JD
    J Immunol; 2004 Sep; 173(6):3953-61. PubMed ID: 15356144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expansion of 2B4+ natural killer (NK) cells and decrease in NKp46+ NK cells in response to influenza.
    Jost S; Reardon J; Peterson E; Poole D; Bosch R; Alter G; Altfeld M
    Immunology; 2011 Apr; 132(4):516-26. PubMed ID: 21214542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unidirectional signaling triggered through 2B4 (CD244), not CD48, in murine NK cells.
    Kim EO; Kim N; Kim TJ; Kim K; Kim TW; Kumar V; Lee KM
    J Leukoc Biol; 2010 Oct; 88(4):707-14. PubMed ID: 20647560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2B4 stimulation of YT cells induces natural killer cell cytolytic function and invasiveness.
    Chuang SS; Kim MH; Johnson LA; Albertsson P; Kitson RP; Nannmark U; Goldfarb RH; Mathew PA
    Immunology; 2000 Jul; 100(3):378-83. PubMed ID: 10929061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD48 stimulation by 2B4 (CD244)-expressing targets activates human NK cells.
    Messmer B; Eissmann P; Stark S; Watzl C
    J Immunol; 2006 Apr; 176(8):4646-50. PubMed ID: 16585556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Of mice and men: different functions of the murine and human 2B4 (CD244) receptor on NK cells.
    Vaidya SV; Mathew PA
    Immunol Lett; 2006 Jun; 105(2):180-4. PubMed ID: 16621032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impairment in cytotoxicity and expression of NK cell- activating receptors on human NK cells following exposure to asbestos fibers.
    Nishimura Y; Miura Y; Maeda M; Kumagai N; Murakami S; Hayashi H; Fukuoka K; Nakano T; Otsuki T
    Int J Immunopathol Pharmacol; 2009; 22(3):579-90. PubMed ID: 19822075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human choriocarcinoma cell resistance to natural killer lysis due to defective triggering of natural killer cells.
    Avril T; Iochmann S; Brand D; Bardos P; Watier H; Thibault G
    Biol Reprod; 2003 Aug; 69(2):627-33. PubMed ID: 12724286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activating interactions in human NK cell recognition: the role of 2B4-CD48.
    Nakajima H; Cella M; Langen H; Friedlein A; Colonna M
    Eur J Immunol; 1999 May; 29(5):1676-83. PubMed ID: 10359122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p46, a novel natural killer cell-specific surface molecule that mediates cell activation.
    Sivori S; Vitale M; Morelli L; Sanseverino L; Augugliaro R; Bottino C; Moretta L; Moretta A
    J Exp Med; 1997 Oct; 186(7):1129-36. PubMed ID: 9314561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition.
    Moretta A; Bottino C; Pende D; Tripodi G; Tambussi G; Viale O; Orengo A; Barbaresi M; Merli A; Ciccone E
    J Exp Med; 1990 Dec; 172(6):1589-98. PubMed ID: 2147946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recognition of viral hemagglutinins by NKp44 but not by NKp30.
    Arnon TI; Lev M; Katz G; Chernobrov Y; Porgador A; Mandelboim O
    Eur J Immunol; 2001 Sep; 31(9):2680-9. PubMed ID: 11536166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.